chloroquine has been researched along with pevonedistat in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, P; Chu, Y; Dong, Z; Hoffman, RM; Hu, T; Jeong, LS; Jia, L; Jiang, Y; Li, C; Li, P; Liang, Y; Pan, Y; Qi, H; Wei, D; Yang, M; Zhang, P | 1 |
Broxmeyer, HE; Lahm, T; Lakhter, AJ; Naidu, SR | 1 |
2 other study(ies) available for chloroquine and pevonedistat
Article | Year |
---|---|
Synergistic inhibition of autophagy and neddylation pathways as a novel therapeutic approach for targeting liver cancer.
Topics: Antineoplastic Agents; Apoptosis Regulatory Proteins; Autophagy; Carcinoma, Hepatocellular; Cell Line, Tumor; Chloroquine; Cyclopentanes; DNA Damage; Drug Synergism; Gene Expression Regulation, Neoplastic; Humans; Liver Neoplasms; Macrolides; Molecular Targeted Therapy; NEDD8 Protein; Neoplasm Proteins; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-bcl-2; Pyrimidines; Random Allocation; RNA, Small Interfering; Transfection; Ubiquitins; Xenograft Model Antitumor Assays | 2015 |
Golgi Associated HIF1a Serves as a Reserve in Melanoma Cells.
Topics: Amino Acids, Dicarboxylic; Cell Hypoxia; Cell Line, Tumor; Cell Nucleus; Chloroquine; Cyclopentanes; Endoplasmic Reticulum; Gene Expression Regulation, Neoplastic; Golgi Apparatus; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Lysosomes; Melanocytes; Oxygen; Prolyl Hydroxylases; Prolyl-Hydroxylase Inhibitors; Proteasome Endopeptidase Complex; Protein Folding; Protein Transport; Proteolysis; Pyrimidines; RNA, Messenger; Signal Transduction; Transcription, Genetic | 2016 |